Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ACETO CORPex99-1.htm
EX-23.1 - EXHIBIT 23.1 - ACETO CORPex23-1.htm
8-K/A - FORM 8-K (AMENDMENT NO. 1) - ACETO CORPt79705_8ka.htm


Exhibit 99.2
 
Aceto Corporation
 
UNAUDITED PRO FORMA FINANCIAL INFORMATION (in thousands)

On April 30, 2014, Rising Pharmaceuticals, Inc., a wholly owned subsidiary of Aceto Corporation (“Aceto” or the “Company”), acquired 100% of the issued and outstanding membership interests of PACK Pharmaceuticals, LLC (“PACK”). PACK, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products, has headquarters in Buffalo Grove, Illinois, a suburb of Chicago. The purchase price was approximately $91,596 which was comprised of the issuance of 260 shares of Aceto common stock, valued at $5,685 and a cash payment of approximately $85,911. The purchase agreement also provides for a three-year earn-out of up to $15,000 in cash based on the achievement of certain performance-based targets. As of April 30, 2014, the Company had accrued $3,725 related to this contingent consideration.

The following unaudited pro forma combined financial statements reflect the acquisition of 100% of the membership interests of PACK using the purchase method of accounting. The acquisition has been accounted for in conformity with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 805, Business Combinations (“ASC 805”). The pro forma adjustments are based upon available information and assumptions that we believe are reasonable. The pro forma adjustments are preliminary and have been prepared to illustrate the estimated effect of the acquisition. Differences between these preliminary estimates and the final acquisition accounting will occur and these differences could have a material impact on the accompanying unaudited pro forma combined financial statements and the combined companies’ future results of operations and financial position. The unaudited pro forma combined financial statements do not purport to be indicative of the operating results or financial position that would have been achieved had the acquisition taken place on the date indicated or the results that may be obtained in the future.

The unaudited pro forma combined balance sheet as of December 31, 2013 is presented as if our acquisition of 100% of the membership interests of PACK had occurred on December 31, 2013.
 
The unaudited pro forma combined consolidated statements of income for the year ended June 30, 2013 and the six months ended December 31, 2013 illustrate the effect of the PACK acquisition as if it had occurred on July 1, 2012. The unaudited pro forma combined consolidated statement of income for the year ended June 30, 2013 combines the historical audited statement of income of Aceto for the year ended June 30, 2013 and PACK’s historical unaudited statement of income for the twelve months ended June 30, 2013. PACK’s fiscal year ended on December 31 and thus, the twelve month period was compiled by combining each quarterly statement of income for each period from July 1, 2012 to June 30, 2013. The unaudited pro forma combined consolidated statement of income for the six months ended December 31, 2013 combines the historical unaudited statement of income of both Aceto and PACK for the six months ended December 31, 2013. The historical consolidated financial information has been adjusted to give effect to pro forma events that are (i) directly attributable to the acquisition, (ii) factually supportable, and (iii) with respect to the statements of income, expected to have a continuing impact on the combined results of the companies. These unaudited pro forma condensed combined financial statements are prepared by management for informational purposes only in accordance with Article 11 of Securities and Exchange Commission Regulation S-X and are not necessarily indicative of future results or of actual results that would have been achieved had the acquisition been consummated as of the dates presented, and should not be taken as representative of future consolidated operating results of Aceto. The unaudited pro forma combined financial statements do not reflect any operating efficiencies and/or cost savings that we may achieve, or any additional expenses or costs of integration that we may incur, with respect to the combined companies as such adjustments are not factually supportable at this point in time. The assumptions used to prepare the pro forma financial information are contained in the notes to the unaudited pro forma combined financial statements, and such assumptions should be reviewed in their entirety.

The unaudited pro forma combined financial statements have been developed from and should be read in conjunction with (i) the historical audited consolidated financial statements for the year ended June 30, 2013 and notes thereto of Aceto contained in its Annual Report on Form 10-K , (ii) the historical unaudited consolidated financial statements and notes thereto of Aceto contained in its Quarterly Report on Form 10-Q for the quarter ended December 31, 2013 and (iii) historical audited financial statements and notes thereto of PACK, included in exhibit 99.1 of this Current Report on Form 8-K.
 
1
 

 

 
ACETO CORPORATION
Unaudited Pro Forma Combined Balance Sheet
December 31, 2013
(In thousands)
                         
   
Aceto
   
PACK
             
   
December 31,
   
December 31,
             
   
2013
   
2013
   
Pro Forma
   
Pro Forma
 
   
Historical
   
Historical
   
Adjustments
   
Combined
 
                         
ASSETS
                       
Current assets:
                       
Cash and cash equivalents
  $ 41,967     $ 3,238     $ (3,238)
  (A)
  $ 41,967  
Investments
    1,693       -       -       1,693  
Trade receivables, less allowance
    87,966       9,372       -       97,338  
for doubtful accounts
                               
Other receivables
    5,663       627       6,168
  (F)
    12,458  
Inventory
    94,651       5,364       307
  (B)
    100,322  
Prepaid expenses and other
    3,043       360               3,403  
current assets
                               
Deferred income tax asset, net
    885       -       -       885  
Total current assets
    235,868       18,961       3,237       258,066  
                                 
Property and equipment, net
    11,443       348       -       11,791  
Property held for sale
    4,058       -       -       4,058  
Goodwill
    33,804       -       31,031
  (I)
    64,835  
Intangible assets, net
    38,894       -       52,540
  (E)
    91,434  
Deferred income tax asset, net
    8,106       -       -       8,106  
Other assets
    7,589       -       -       7,589  
                                 
TOTAL ASSETS
  $ 339,762     $ 19,309     $ 86,808     $ 445,879  
                                 
LIABILITIES AND
                               
SHAREHOLDERS’ EQUITY
                               
Current liabilities:
                               
Accounts payable
  $ 40,066     $ 2,862     $ -     $ 42,928  
Current portion of long-term
    8,197       3,151       4,849
  (C)
    16,197  
debt
                               
Accrued expenses
    41,710       7,918       1,311
  (D)
    50,939  
                                 
Total current liabilities
    89,973       13,931       6,160       110,064  
                                 
Long-term debt
    16,256       -       77,911
  (C)
    94,167  
Long-term liabilities
    11,183       16       3,725
  (G)
    14,924  
Environmental remediation liability
    4,319       -               4,319  
Deferred income tax liability
    9       -       -       9  
Total liabilities
    121,740       13,947       87,796       223,483  
                                 
                                 
Shareholders’ equity:
                               
Common stock
    284       -       3
  (H)
    287  
Capital in excess of par value
    78,304       -       5,682
  (H)
    83,986  
Partners equity’
    -       (18,641 )     18,641
  (J)
    -  
Retained earnings
    133,304       24,003       (1,311)
  (D)
    131,993  
                      (24,003)
  (J)
       
Accumulated other
                               
comprehensive income
    6,130       -       -       6,130  
Total shareholders’ equity
    218,022       5,362       (988)       222,396  
                                 
                                 
TOTAL LIABILITIES AND
  $ 339,762     $ 19,309     $ 86,808     $ 445,879  
SHAREHOLDERS’ EQUITY
                               
 
See the accompanying notes to the Pro Forma Combined Financial Statements
 
2
 

 

 
ACETO CORPORATION
Unaudited Pro Forma Combined Statement of Income
For The Year Ended June 30, 2013
(In thousands, except per share amounts)
                           
   
Aceto
   
PACK
               
   
for the
   
for the
               
   
year ended
   
twelve months ended
               
   
June 30, 2013
   
June 30, 2013
   
Pro Forma
     
Pro Forma
 
   
Historical
   
Historical
   
Adjustments
     
Combined
 
                           
Net sales
  $ 499,690     $ 38,368     $       $ 538,058  
Cost of sales
    401,419       23,196               424,615  
Gross profit
    98,271       15,172       -         113,443  
                                   
Selling, general and administrative expenses
    63,855       10,144       4,783
  (K)
      78,782  
                                   
Operating income
    34,416       5,028       (4,783)         34,661  
                                   
Other income (expense):
                                 
Interest expense
    (2,122 )     -       (3,007)   (L)       (5,536 )
                      (407)   (M)          
Interest and other income, net
    2,256       -                 2,256  
      134       -       (3,414)         (3,280 )
                                   
Income before income taxes
    34,550       5,028       (8,197)         31,381  
                                   
Income tax provision
    12,222       -       (1,236)   (N)       10,986  
Net income
  $ 22,328     $ 5,028     $ (6,961)       $ 20,395  
                                   
                                   
Net income per common share
  $ 0.83                       $ 0.75  
Diluted net income per common share
  $ 0.81                       $ 0.74  
                                   
Weighted average shares outstanding:
                                 
Basic
    27,050       260                 27,310  
Diluted
    27,450       260                 27,710  
 
See the accompanying notes to the Pro Forma Combined Financial Statements
 
3
 

 

 
ACETO CORPORATION
Unaudited Pro Forma Combined Statement of Income
For The Six Months Ended December 31, 2013
(In thousands, except per share amounts)
                         
   
Aceto
   
PACK
             
   
for the
   
for the
             
   
six months ended
   
six months ended
             
   
December 31,
2013
   
December 31,
2013
   
Pro Forma
   
Pro Forma
 
   
Historical
   
Historical
   
Adjustments
   
Combined
 
                         
Net sales
  $ 245,769     $ 25,964   $       $ 271,733  
Cost of sales
    185,051        15,396             200,447  
      Gross profit
    60,718       10,568       -       71,286  
                                 
Selling, general and administrative expenses
    32,559       6,522       2,392
  (K)
    41,473  
                                 
Operating income
    28,159       4,046       (2,392)       29,813  
                                 
Other income (expense):
                               
       Interest expense
    (890 )     -       (1,503)   (L)     (2,634 )
                      (241)   (M)        
       Interest and other income, net
    1,035       -               1,035  
      145       -       (1,744)       (1,599 )
                                 
Income before income taxes
    28,304       4,046       (4,136)       28,214  
                                 
Income tax provision
    10,214       -       (35)   (N)     10,179  
Net income
  $ 18,090     $ 4,046     $ (4,101)     $ 18,035  
                                 
                                 
Net income per common share
  $ 0.65                     $ 0.64  
Diluted net income per common share
  $ 0.64                     $ 0.63  
                                 
Weighted average shares outstanding:
                               
                                 
      Basic
    27,790       260               28,050  
                                 
      Diluted
    28,404       260               28,664  
 
See the accompanying notes to the Pro Forma Combined Financial Statements
 
4
 

 

 
ACETO CORPORATION
Notes to Unaudited Pro Forma Combined Financial Statements
(In thousands, except per share amounts)
 
1.           Background and Basis of Pro Forma Presentation

On April 30, 2014, Rising Pharmaceuticals, Inc., a wholly owned subsidiary of Aceto Corporation (“Aceto” or the “Company”), acquired 100% of the issued and outstanding membership interests of PACK Pharmaceuticals, LLC (“PACK”). PACK, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products, has headquarters in Buffalo Grove, Illinois, a suburb of Chicago.

The unaudited pro forma combined financial information was prepared based on the historical financial statements of Aceto and PACK.

Our acquisition has been accounted for in conformity with ASC 805 and uses the fair value concepts defined in Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820-10”). ASC 805 requires, among other things, that most assets acquired and liabilities assumed in an acquisition be recognized at their fair values as of the acquisition date and requires that fair value be measured based on the principles in ASC 820-10. ASC 820-10 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 also requires that a fair value measurement reflect the assumptions market participants would use in pricing an asset or liability based on the best information available.
 
2.           Purchase Price Allocation

The acquisition is accounted for using the acquisition method of accounting. The total estimated purchase price is comprised of the following:
         
Cash paid at initial closing
  $ 85,911  
Common stock issued
    5,685  
Estimated fair value of additional contingent consideration
    3,725  
    $ 95,321  
 
5
 

 

 
The following table summarizes the preliminary allocation of the purchase price to the estimated fair values of the assets acquired and liabilities assumed on the closing date of April 30, 2014 as if the acquisition had occurred on December 31, 2013.
 
         
Trade receivables
    9,372  
Other receivables
    6,795  
Inventory
    5,671  
Prepaid expenses and other current assets
    360  
Property and equipment, net
    348  
Goodwill
    31,031  
Intangible assets
    52,540  
  Total assets acquired
    106,117  
         
Accounts payable
    2,862  
Accrued expenses
    7,934  
         
Net assets acquired
  $ 95,321  
 
3.           Pro Forma Financial Statement Adjustments

The following pro forma adjustments are included in the Company’s unaudited pro forma combined financial statements:

   A.
To eliminate PACK’s cash as the agreement stated that acquired working capital would exclude cash.

   B.
Adjustment to record a $307 step-up in the fair value of inventory.

   C.
To reflect $85,911 of bank borrowings used to finance the acquisition and the pay-off of $3,151 of bankers’ acceptances included on PACK’s balance sheet.

   D.
To reflect after tax impact of non-recurring acquisition-related transaction costs.

   E.
To record the preliminary estimate of the fair value of intangible assets for our acquisition of PACK. The amortizable intangible assets acquired are comprised of the following:  approximately $38,280 of product rights, amortizable over a period of approximately eleven years; approximately $14,170 of customer relationships, amortizable over eleven years; and approximately $90 of trademarks, amortizable over a period of three years.

   F.
To reflect working capital adjustment calculated in accordance with the purchase agreement.

   G.
To reflect the fair value of additional contingent consideration of $3,725.  The purchase agreement provides for a three-year earn-out of up to $15,000 in cash based on the achievement of certain performance-based targets. The contingent consideration was calculated using the present value of a probability weighted income approach.

   H.
To reflect 260 shares of Aceto common stock issued in connection with the acquisition of PACK, valued at $21.88, the closing price of Aceto stock on the closing date.
 
6
 

 

 
   I.
To record the preliminary estimate of goodwill for our acquisition of PACK of $31,031. Goodwill represents the excess of the purchase price paid over the fair value of the underlying net assets of the business acquired.

   J.
To eliminate PACK’s historical partners’ equity.

   K.
Adjustment to record the amortization expense related to the amortizable intangible assets acquired, which is computed by the straight-line method over their estimated useful lives.

   L.
To reflect increase in interest expense associated with bank borrowings to fund the acquisition.  On April 28, 2014, we borrowed $15,911 of Revolving Loans and a Term Loan of $70,000.

   M.
To reflect interest expense associated with the discount of the contingent consideration.

   N.
Adjustment to record an income tax provision for PACK and pro forma adjustments using a 39% tax rate. Prior to the acquisition, PACK was a Limited Liability Corporation and was not taxed at the Corporation level.
 
The pro forma adjustments included in the income statements do not give effect to the impact on gross profit of the adjustment to increase inventory by approximately $307 to its estimated fair value and the impact of non-recurring acquisition-related transaction costs of approximately $2,149.
 
7